OnCo
technologiesTechnologyEmerging

H-optimus (Bioptimus)

An open 1.1-billion-parameter pathology model from a French startup, among the strongest on public benchmarks.

H-optimus-0 (2024) trained on hundreds of millions of tiles from 500k slides; H-optimus-1 followed. Available for research and commercial licensing.

Generic schematic · not to scale · placeholder for the ai computation front
Flagged finding · Neural network

How it works

H-optimus is a ViT-giant pretrained with DINOv2.

Strengths
  • Open weights
  • Benchmark leader on release
Limitations
  • Less clinical validation than commercial products
Since
2024

Latest papers

top
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"H-optimus" OR ABSTRACT:"H-optimus" OR TITLE:"Bioptimus" OR ABSTRACT:"Bioptimus") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about H-optimus (Bioptimus), not a curated reading list.

Connected

3top

Pages like this

not linked directly; found by shared links